首页> 外文学位 >Design and Synthesis of ERK Inhibitors as Potential Cancer Drugs

【24h】

Design and Synthesis of ERK Inhibitors as Potential Cancer Drugs

机译：ERK抑制剂作为潜在癌症药物的设计与合成

获取原文

获取原文并翻译 | 示例

页面导航

著录项
相似文献
相关主题

著录项

作者
LotfalianSaremi, Sajedeh.;
展开▼
作者单位

Stevens Institute of Technology.;

展开▼
授予单位 Stevens Institute of Technology.;
学科
学位 Ph.D.
年度 2020
页码 93 p.
总页数 93
原文格式 PDF
正文语种 eng
中图分类 AAI27961666;
关键词
Potential cancer drugs; ERK inhibitors; MAPK pathway;

机译：潜在的癌症药物;ERK抑制剂;MAPK途径;

相似文献

外文文献
中文文献
专利

1. 新型N-(2-芳基氨基苯基)-2,3-二苯基喹喔啉-6-磺胺类药物作为潜在抗疟疾、抗真菌和抗细菌药物的合理药物设计、合成和生物学评价 [J] . Ahmed Hassen Shntaif, Sharuk Khan, Ganesh Tapadiya, 数字中医药（英文） . 2021 ,第004期
2. Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers [J] . Caolin Wang, Shan Xu, Liang Peng, Journal of enzyme inhibition and medicinal chemistry. . 2019 ,第1期

机译：设计，合成和生物学评估作为EGFR抑制剂的新型4-anlinoquinazoline衍生物具有抑制吉非替尼耐药的非小细胞肺癌的潜力
3. Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs [J] . NakaoS., MabuchiM., ShimizuT., Bioorganic and Medicinal Chemistry Letters . 2014 ,第4期

机译：抗前列腺癌药物前列腺癌抗原1（PCA-1 / ALKBH3）抑制剂的设计与合成
4. Design, synthesis, and evaluation of novel mutual prodrugs (Hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitro [J] . Gediya LK, Khandelwal A, Patel J, Journal of Medicinal Chemistry . 2008 ,第13期

机译：全反式视黄酸和组蛋白脱乙酰基酶抑制剂在乳腺癌和前列腺癌细胞中具有增强的抗癌活性的新型共同药物（混合药物）的设计，合成和评估
5. INHIBITORS OF THE RAS/ERK SIGNALING PATHWAY INCORPORATING THE FXF MOTIF FOR FHE DEVELOPMENT OF ANTICANCER DRUGS [C] . Theodore Skarlas, EugeniaJPanou-Pomonis, Dimitrios Krikorian the European Peptide Symposium . 2007

机译：RAS / ERK信号传导途径的抑制剂包括FXF基序用于抗癌药物的发育
6. Activity of Anticancer Drugs in Relation to the Tumour Microenvironment and Potential to Inhibit Repopulation and Enhance Therapeutic Outcome. [D] . Saggar, Jasdeep Kaur. 2014

机译：与肿瘤微环境有关的抗癌药物活性以及抑制再增殖和增强治疗效果的潜力。
7. Innovative Three-Step Microwave-Promoted Synthesis of N-Propargyltetrahydroquinoline and 123-Triazole Derivatives as a Potential Factor Xa (FXa) Inhibitors: Drug Design Synthesis and Biological Evaluation [O] . Fabián Santana-Romo, Carlos F. Lagos, Yorley Duarte, 2020

机译：创新的三步微波促进合成N-炔丙基四氢喹啉和123-三唑衍生物作为潜在因子Xa（FXa）抑制剂：药物设计合成和生物学评估
8. Design and synthesis of novel quinazoline-based EGFR kinase inhibitors and dual EGFR/NF-kappa B inhibitors as potential anti-cancer drugs with enhanced efficacy [O] . Hamed Mostafa Mohamed Mostafa 2013

机译：新型基于喹唑啉的EGFR激酶抑制剂和EGFR /NF-κB双重抑制剂作为潜在抗癌药物的设计和合成
9. Design, Synthesis, and Evaluation of Estrogen Sulfotransferase Inhibitors: Potential Enhancers of Tamoxifen-Mediated Apoptosis in ER Negative Breast Cancers [R] . Peterson, B. R. 2002

机译：雌激素磺基转移酶抑制剂的设计，合成和评价：他莫昔芬介导的ER阴性乳腺癌细胞凋亡的潜在增强剂

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号